Pituitary Tissue Cell Mass Formation via 3D Stem Cell Aggregation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing pituitary tissue from pluripotent stem cells are inefficient and do not replicate the complex structure necessary for functional pituitary tissue, and they require expensive recombinant proteins.
Innovation Solution
A method involving suspension culture of pluripotent stem cells with specific signaling pathway inhibitors and activators, such as Wnt, BMP, and Sonic hedgehog, in the absence of feeder cells, to form a cell mass containing pituitary tissue, optimizing conditions like timing and concentration of BMP addition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If pluripotent stem cells are cultured using existing methods with BMP and Sonic hedgehog signaling pathway activators, then pituitary cells can be produced, but the complex three-dimensional structure of pituitary tissue is not reproduced and production efficiency is low
Solution Approach 1:
The patent applies preliminary action by first forming cell aggregates from pluripotent stem cells before exposing them to BMP and Sonic hedgehog signaling pathway activators. This pre-aggregation step creates a three-dimensional structure that mimics native pituitary tissue architecture, enabling subsequent differentiation to occur within a structurally appropriate framework rather than on a two-dimensional substrate.
Solution Approach 2:
The patent transitions from two-dimensional culture to three-dimensional tissue structure formation by cultivating cell aggregates in suspension. This dimensional change allows cells to self-organize into complex three-dimensional pituitary tissue structures that replicate the native organ's architecture, which is essential for functional reproduction.
2Reliability
If conventional culture methods are used to produce pituitary tissue, then differentiation can occur, but expensive recombinant proteins are required and production costs are high
Solution Approach 1:
The patent applies self-service by utilizing the endogenous signaling pathways within pluripotent stem cells to drive pituitary differentiation. By activating BMP and Sonic hedgehog pathways through small molecules or natural ligands rather than expensive recombinant proteins, the system leverages its own intrinsic differentiation potential, reducing external resource requirements and production costs.
Solution Approach 2:
The patent changes the parameters of differentiation induction by using alternative activators for BMP and Sonic hedgehog signaling pathways that are less expensive than conventional recombinant proteins. This parameter substitution maintains reliable pituitary cell differentiation while significantly reducing the quantity and cost of expensive substances required.
3Ease of operation
If feeder cells are used to culture pluripotent stem cells, then cell maintenance is easier, but the complexity of the culture system increases and costs increase
Solution Approach 1:
The patent applies taking out by removing feeder cells from the culture system entirely. Pluripotent stem cells are maintained and differentiated in a feeder-free condition using defined culture media and small molecule activators, simplifying the overall culture system while maintaining ease of operation through standardized, cell-free protocols.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method efficiently produces high-quality pituitary tissue with reduced costs by minimizing the use of expensive recombinant proteins and replicates the complex structure of pituitary tissue.
Implementation Method 1
a first step of suspension-culturing pluripotent stem cells to form a cell aggregate in the presence of a Wnt signal transduction pathway inhibiting substance
Implementation Method 2
a second step of suspension-culturing the aggregate obtained in the first step in the presence of a BMP signal transduction pathway activating substance
Implementation Method 3
a second step of suspension-culturing the aggregate obtained in the first step in the presence of a Sonic hedgehog signal transduction pathway activating substance
Data Source
AI summary
The present invention aims to provide a method for efficiently producing a cell mass containing pituitary tissue from pluripotent stem cells. A method for producing a cell mass containing pituitary tissue, including the following steps (1) and (2):(1) a first step of suspension-culturing pluripotent stem cells to form a cell aggregate in the presence of a Wnt signal transduction pathway inhibiting substance,(2) a second step of suspension-culturing the aggregate obtained in the first step in the presence of a BMP signal transduction pathway activating substance and a Sonic hedgehog signal transduction pathway activating substance, thereby obtaining a cell mass comprising pituitary tissue.